{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:24:22Z","timestamp":1794842662072,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["28733"],"award-info":[{"award-number":["28733"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cancer cells adapt to harsh environmental conditions by inducing the Unfolded Protein Response (UPR), of which ERO1A is a mediator. ERO1A aids protein folding by acting as a protein disulfide oxidase, and under cancer-related hypoxia conditions, it favors the folding of angiogenic VEGFA, leading tumor cells to thrive and spread. The upregulation of ERO1A in cancer cells, oppositely to the dispensability of ERO1A activity in healthy cells, renders ERO1A a perfect target for cancer therapy. Here, we report the upregulation of ERO1A in a cohort of aggressive triple-negative breast cancer (TNBC) patients in which ERO1A levels correlate with a higher risk of breast tumor recurrence and metastatic spread. For ERO1A target validation and therapy in TNBC, we designed new ERO1A inhibitors in a structure-activity campaign of the prototype EN460. Cell-based screenings showed that the presence of the Micheal acceptor in the compound is necessary to engage the cysteine 397 of ERO1A but not sufficient to set out the inhibitory effect on ERO1A. Indeed, the ERO1 inhibitor must adopt a non-coplanar rearrangement within the ERO1A binding site. I2 and I3, two new EN460 analogs with different phenyl-substituted moieties, efficiently inhibited ERO1A, blunting VEGFA secretion. Accordingly, in vitro assays to measure ERO1A engagement and inhibition confirmed that I2 and I3 bind ERO1A and restrain its activity with a IC50 in a low micromolar range. EN460, I2 and I3 triggered breast cancer cytotoxicity while specifically inhibiting ERO1A in a dose-dependent manner. I2 more efficiently impaired cancer-relevant features such as VEGFA secretion and related cell migration. I2 also acted on the tumor microenvironment and viability of xenografts and syngeneic TNBC. Thus, small molecule-mediated ERO1A pharmacological inhibition is feasible and promises to lead to effective therapy for the still incurable TNBC.<\/jats:p>","DOI":"10.1038\/s41419-025-07426-1","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:09:12Z","timestamp":1739848152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment"],"prefix":"10.1038","volume":"16","author":[{"given":"Ersilia","family":"Varone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-8505","authenticated-orcid":false,"given":"Michele","family":"Retini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-5688","authenticated-orcid":false,"given":"Alexander","family":"Chernorudskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Marrazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Guidarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Cagnotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marten","family":"Beeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-6225","authenticated-orcid":false,"given":"Marco","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-3345","authenticated-orcid":false,"given":"Luca","family":"Guarrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-0032","authenticated-orcid":false,"given":"Maria Chiara","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Bleve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Generali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-3587","authenticated-orcid":false,"given":"Michele","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-9873","authenticated-orcid":false,"given":"Mario","family":"Salmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Piersanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-583X","authenticated-orcid":false,"given":"Giovanni","family":"Bottegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-9358","authenticated-orcid":false,"given":"Massimo","family":"Broggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M. W.","family":"Janssen-Heininger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7182-802X","authenticated-orcid":false,"given":"Orazio","family":"Cantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-7698","authenticated-orcid":false,"given":"Ester","family":"Zito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"7426_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.997235","volume":"12","author":"A Cherubini","year":"2022","unstructured":"Cherubini A, Zito E. ER stress as a trigger of UPR and ER-phagy in cancer growth and spread. Front Oncol 2022;12:997235.","journal-title":"Front Oncol"},{"key":"7426_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer 2021;21:71\u201388.","journal-title":"Nat Rev Cancer"},{"key":"7426_CR3","doi-asserted-by":"crossref","unstructured":"Rodvold JJ, Chiu KT, Hiramatsu N, Nussbacher JK, Galimberti V, Mahadevan NR, et al. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Sci Signal. 2017;10.","DOI":"10.1126\/scisignal.aah7177"},{"key":"7426_CR4","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1158\/0008-5472.CAN-12-0474","volume":"72","author":"Y Wang","year":"2012","unstructured":"Wang Y, Alam GN, Ning Y, Visioli F, Dong Z, Nor JE, et al. The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK\/ATF4 pathway. Cancer Res 2012;72:5396\u2013406.","journal-title":"Cancer Res"},{"key":"7426_CR5","doi-asserted-by":"crossref","unstructured":"Manuelli V, Pecorari C, Filomeni G, Zito E. Regulation of redox signaling in HIF-1-dependent tumor angiogenesis. FEBS J. 2021.","DOI":"10.1111\/febs.16110"},{"key":"7426_CR6","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-19-3108","volume":"80","author":"JM Harnoss","year":"2020","unstructured":"Harnoss JM, Le Thomas A, Reichelt M, Guttman O, Wu TD, Marsters SA, et al. IRE1alpha Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment. Cancer Res 2020;80:2368\u201379.","journal-title":"Cancer Res"},{"key":"7426_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1097-2765(00)80018-0","volume":"1","author":"MG Pollard","year":"1998","unstructured":"Pollard MG, Travers KJ, Weissman JS. Ero1p: a novel and ubiquitous protein with an essential role in oxidative protein folding in the endoplasmic reticulum. Mol Cell 1998;1:171\u201382.","journal-title":"Mol Cell"},{"key":"7426_CR8","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.7150\/thno.45124","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang J, Lin C, Liu W, Huo Y, Yang M, et al. Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer. Theranostics 2020;10:8400\u201314.","journal-title":"Theranostics"},{"key":"7426_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111899","volume":"42","author":"A Bassot","year":"2023","unstructured":"Bassot A, Chen J, Takahashi-Yamashiro K, Yap MC, Gibhardt CS, Le GNT, et al. The endoplasmic reticulum kinase PERK interacts with the oxidoreductase ERO1 to metabolically adapt mitochondria. Cell Rep 2023;42:111899.","journal-title":"Cell Rep"},{"key":"7426_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molcel.2012.08.010","volume":"48","author":"E Zito","year":"2012","unstructured":"Zito E, Hansen HG, Yeo GS, Fujii J, Ron D. Endoplasmic Reticulum Thiol Oxidase Deficiency Leads to Ascorbic Acid Depletion and Noncanonical Scurvy in Mice. Mol Cell 2012;48:39\u201351.","journal-title":"Mol Cell"},{"key":"7426_CR11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.molcel.2010.11.010","volume":"40","author":"E Zito","year":"2010","unstructured":"Zito E, Melo EP, Yang Y, Wahlander A, Neubert TA, Ron D. Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. Mol Cell 2010;40:787\u201397.","journal-title":"Mol Cell"},{"key":"7426_CR12","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1038\/emboj.2010.273","volume":"29","author":"TJ Tavender","year":"2010","unstructured":"Tavender TJ, Springate JJ, Bulleid NJ. Recycling of peroxiredoxin IV provides a novel pathway for disulphide formation in the endoplasmic reticulum. EMBO J 2010;29:4185\u201397.","journal-title":"EMBO J"},{"key":"7426_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2015.01.011","volume":"83","author":"E Zito","year":"2015","unstructured":"Zito E. ERO1: A protein disulfide oxidase and H2O2 producer. Free Radic Biol Med 2015;83:299\u2013304.","journal-title":"Free Radic Biol Med"},{"key":"7426_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jmb.2010.12.039","volume":"406","author":"VD Nguyen","year":"2011","unstructured":"Nguyen VD, Saaranen MJ, Karala AR, Lappi AK, Wang L, Raykhel IB, et al. Two endoplasmic reticulum PDI peroxidases increase the efficiency of the use of peroxide during disulfide bond formation. J Mol Biol 2011;406:503\u201315.","journal-title":"J Mol Biol"},{"key":"7426_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189027","volume":"1879","author":"E Zito","year":"2023","unstructured":"Zito E, Guarrera L, Janssen-Heininger YMW. Fingerprint of the oxido-reductase ERO1: A protein disulfide bond producer and supporter of cancer. Biochim Biophys Acta Rev Cancer 2023;1879:189027.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7426_CR16","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1111\/bph.15927","volume":"179","author":"E Varone","year":"2022","unstructured":"Varone E, Decio A, Barbera MC, Bolis M, Di Rito L, Pisati F, et al. Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience. Br J Pharm 2022;179:5180\u201395.","journal-title":"Br J Pharm"},{"key":"7426_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.21037\/tau-20-1025","volume":"10","author":"J Cornelius","year":"2021","unstructured":"Cornelius J, Cavarretta I, Pozzi E, Lavorgna G, Locatelli I, Tempio T, et al. Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks. Transl Androl Urol 2021;10:1110\u201320.","journal-title":"Transl Androl Urol"},{"key":"7426_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1083\/jcb.201307185","volume":"203","author":"M Koritzinsky","year":"2013","unstructured":"Koritzinsky M, Levitin F, van den Beucken T, Rumantir RA, Harding NJ, Chu KC, et al. Two phases of disulfide bond formation have differing requirements for oxygen. J Cell Biol 2013;203:615\u201327.","journal-title":"J Cell Biol"},{"key":"7426_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102455","volume":"56","author":"E Varone","year":"2022","unstructured":"Varone E, Chernorudskiy A, Cherubini A, Cattaneo A, Bachi A, Fumagalli S, et al. ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA. Redox Biol 2022;56:102455.","journal-title":"Redox Biol"},{"key":"7426_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","volume":"14","author":"M Wang","year":"2014","unstructured":"Wang M, Kaufman RJ. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer 2014;14:581\u201397.","journal-title":"Nat Rev Cancer"},{"key":"7426_CR21","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938\u201348.","journal-title":"N Engl J Med"},{"key":"7426_CR22","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet 2017;389:2430\u201342.","journal-title":"Lancet"},{"key":"7426_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41388-021-01659-y","volume":"40","author":"E Varone","year":"2021","unstructured":"Varone E, Decio A, Chernorudskiy A, Minoli L, Brunelli L, Ioli F, et al. The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions. Oncogene 2021;40:1721\u201336.","journal-title":"Oncogene"},{"key":"7426_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.onc.1208325","volume":"24","author":"D May","year":"2005","unstructured":"May D, Itin A, Gal O, Kalinski H, Feinstein E, Keshet E. Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. Oncogene 2005;24:1011\u201320.","journal-title":"Oncogene"},{"key":"7426_CR25","doi-asserted-by":"crossref","unstructured":"Zilli F, Marques Ramos P, Auf der Maur P, Jehanno C, Sethi A, Coissieux MM, et al. The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells. EMBO Mol Med. 2021:e13162.","DOI":"10.15252\/emmm.202013162"},{"key":"7426_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bjc.2016.105","volume":"114","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Kutomi G, Kajiwara T, Kukita K, Kochin V, Kanaseki T, et al. Cancer-associated oxidoreductase ERO1-alpha drives the production of VEGF via oxidative protein folding and regulating the mRNA level. Br J Cancer 2016;114:1227\u201334.","journal-title":"Br J Cancer"},{"key":"7426_CR27","doi-asserted-by":"publisher","first-page":"20993","DOI":"10.1074\/jbc.M110.126599","volume":"285","author":"JD Blais","year":"2010","unstructured":"Blais JD, Chin KT, Zito E, Zhang Y, Heldman N, Harding HP, et al. A small molecule inhibitor of endoplasmic reticulum oxidation 1 (ERO1) with selectively reversible thiol reactivity. J Biol Chem 2010;285:20993\u20131003.","journal-title":"J Biol Chem"},{"key":"7426_CR28","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1038\/emboj.2010.222","volume":"29","author":"K Inaba","year":"2010","unstructured":"Inaba K, Masui S, Iida H, Vavassori S, Sitia R, Suzuki M. Crystal structures of human Ero1alpha reveal the mechanisms of regulated and targeted oxidation of PDI. EMBO J 2010;29:3330\u201343.","journal-title":"EMBO J"},{"key":"7426_CR29","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, et al. OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J Chem Theory Comput 2021;17:4291\u2013300.","journal-title":"J Chem Theory Comput"},{"key":"7426_CR30","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1021\/cr9904009","volume":"105","author":"J Tomasi","year":"2005","unstructured":"Tomasi J, Mennucci B, Cammi R. Quantum mechanical continuum solvation models. Chem Rev 2005;105:2999\u20133093.","journal-title":"Chem Rev"},{"key":"7426_CR31","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1161\/CIRCRESAHA.122.322473","volume":"132","author":"V Jha","year":"2023","unstructured":"Jha V, Xiong B, Kumari T, Brown G, Wang J, Kim K, et al. A Critical Role for ERO1alpha in Arterial Thrombosis and Ischemic Stroke. Circ Res 2023;132:e206\u201322.","journal-title":"Circ Res"},{"key":"7426_CR32","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-08-0041","volume":"68","author":"W Cruz-Munoz","year":"2008","unstructured":"Cruz-Munoz W, Man S, Xu P, Kerbel RS. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res 2008;68:4500\u20135.","journal-title":"Cancer Res"},{"key":"7426_CR33","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1083\/jcb.200911086","volume":"188","author":"E Zito","year":"2010","unstructured":"Zito E, Chin KT, Blais J, Harding HP, Ron D. ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis. J Cell Biol 2010;188:821\u201332.","journal-title":"J Cell Biol"},{"key":"7426_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.redox.2018.10.017","volume":"20","author":"D Pozzer","year":"2018","unstructured":"Pozzer D, Varone E, Chernorudskiy A, Schiarea S, Missiroli S, Giorgi C, et al. A maladaptive ER stress response triggers dysfunction in highly active muscles of mice with SELENON loss. Redox Biol 2018;20:354\u201366.","journal-title":"Redox Biol"},{"key":"7426_CR35","doi-asserted-by":"publisher","first-page":"10864","DOI":"10.3390\/s140610864","volume":"14","author":"M Canovi","year":"2014","unstructured":"Canovi M, Lucchetti J, Stravalaci M, Valentino S, Bottazzi B, Salmona M, et al. A new surface plasmon resonance-based immunoassay for rapid, reproducible and sensitive quantification of pentraxin-3 in human plasma. Sens (Basel) 2014;14:10864\u201375.","journal-title":"Sens (Basel)"},{"key":"7426_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer 2010;102:1555\u201377.","journal-title":"Br J Cancer"},{"key":"7426_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03565-8","volume":"21","author":"T Castrignano","year":"2020","unstructured":"Castrignano T, Gioiosa S, Flati T, Cestari M, Picardi E, Chiara M, et al. ELIXIR-IT HPC@CINECA: high performance computing resources for the bioinformatics community. BMC Bioinforma 2020;21:352.","journal-title":"BMC Bioinforma"},{"key":"7426_CR38","doi-asserted-by":"publisher","first-page":"D711","DOI":"10.1093\/nar\/gky964","volume":"47","author":"A Athar","year":"2019","unstructured":"Athar A, Fullgrabe A, George N, Iqbal H, Huerta L, Ali A, et al. ArrayExpress update - from bulk to single-cell expression data. Nucleic Acids Res 2019;47:D711\u20135.","journal-title":"Nucleic Acids Res"},{"key":"7426_CR39","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1021\/acs.joc.2c01050","volume":"87","author":"F Bartoccini","year":"2022","unstructured":"Bartoccini F, Retini M, Crinelli R, Menotta M, Fraternale A, Piersanti G. Dithiol Based on l-Cysteine and Cysteamine as a Disulfide-Reducing Agent. J Org Chem 2022;87:10073\u20139.","journal-title":"J Org Chem"},{"key":"7426_CR40","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/emboj.2010.203","volume":"29","author":"C Appenzeller-Herzog","year":"2010","unstructured":"Appenzeller-Herzog C, Riemer J, Zito E, Chin KT, Ron D, Spiess M, et al. Disulphide production by Ero1alpha-PDI relay is rapid and effectively regulated. EMBO J 2010;29:3318\u201329.","journal-title":"EMBO J"},{"key":"7426_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/11047","volume":"1","author":"JW Cuozzo","year":"1999","unstructured":"Cuozzo JW, Kaiser CA. Competition between glutathione and protein thiols for disulphide-bond formation. Nat Cell Biol 1999;1:130\u20135.","journal-title":"Nat Cell Biol"},{"key":"7426_CR42","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1172\/JCI85506","volume":"126","author":"LN Kent","year":"2016","unstructured":"Kent LN, Rakijas JB, Pandit SK, Westendorp B, Chen HZ, Huntington JT, et al. E2f8 mediates tumor suppression in postnatal liver development. J Clin Invest 2016;126:2955\u201369.","journal-title":"J Clin Invest"},{"key":"7426_CR43","doi-asserted-by":"crossref","unstructured":"Liu L, Li S, Qu Y, Bai H, Pan X, Wang J, et al. Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity. Cell Rep Med. 2023:101206.","DOI":"10.1016\/j.xcrm.2023.101206"},{"key":"7426_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and Function of the PD-L1 Checkpoint. Immunity 2018;48:434\u201352.","journal-title":"Immunity"},{"key":"7426_CR45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ebiom.2019.02.041","volume":"41","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li T, Zhang L, Shangguan F, Shi G, Wu X, et al. Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1alpha and protein disulfide isomerase suppresses the progression of cervical cancer. EBioMedicine 2019;41:408\u201319.","journal-title":"EBioMedicine"},{"key":"7426_CR46","doi-asserted-by":"publisher","first-page":"16369","DOI":"10.1073\/pnas.1113483108","volume":"108","author":"CC Wong","year":"2011","unstructured":"Wong CC, Gilkes DM, Zhang H, Chen J, Wei H, Chaturvedi P, et al. Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci USA 2011;108:16369\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7426_CR47","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.bmc.2019.02.016","volume":"27","author":"KE Hayes","year":"2019","unstructured":"Hayes KE, Batsomboon P, Chen WC, Johnson BD, Becker A, Eschrich S, et al. Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma. Bioorg Med Chem 2019;27:1479\u201388.","journal-title":"Bioorg Med Chem"},{"key":"7426_CR48","doi-asserted-by":"crossref","unstructured":"Stafford WC, Peng X, Olofsson MH, Zhang X, Luci DK, Lu L, et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018;10.","DOI":"10.1126\/scitranslmed.aaf7444"},{"key":"7426_CR49","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","volume":"21","author":"L Boike","year":"2022","unstructured":"Boike L, Henning NJ, Nomura DK. Advances in covalent drug discovery. Nat Rev Drug Discov 2022;21:881\u201398.","journal-title":"Nat Rev Drug Discov"},{"key":"7426_CR50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.critrevonc.2011.11.010","volume":"83","author":"SH Ou","year":"2012","unstructured":"Ou SH. Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence. Crit Rev Oncol Hematol 2012;83:407\u201321.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7426_CR51","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s40265-017-0811-4","volume":"77","author":"ED Deeks","year":"2017","unstructured":"Deeks ED. Neratinib: First Global Approval. Drugs 2017;77:1695\u2013704.","journal-title":"Drugs"},{"key":"7426_CR52","doi-asserted-by":"crossref","unstructured":"Germani S, Van Ho AT, Cherubini A, Varone E, Chernorudskiy A, Renna GM, et al. SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA. Cell Rep Med. 2024:101439.","DOI":"10.1016\/j.xcrm.2024.101439"},{"key":"7426_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/CIRCRESAHA.121.320531","volume":"130","author":"S Hamilton","year":"2022","unstructured":"Hamilton S, Terentyeva R, Bogdanov V, Kim TY, Perger F, Yan J, et al. Ero1alpha-Dependent ERp44 Dissociation From RyR2 Contributes to Cardiac Arrhythmia. Circ Res 2022;130:711\u201324.","journal-title":"Circ Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07426-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07426-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07426-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T03:09:21Z","timestamp":1739848161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07426-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7426"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07426-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human studies were approved by the local ethical committee of \u201cAzienda Socio-Sanitaria Territoriale of Cremona\u201d (RaLCTrVs1Ott_2000). All patients participated in this study provided written informed consents in accordance with the Declaration of Helsinki. Mouse studies are reported in compliance with the ARRIVE guidelines and conducted in conformity with the following laws, regulations and policies governing the care and use of laboratory animals: Italian Governing Law (D.lgs 26\/2014, authorization 19\/2008-A issued 6 March 2008 by Ministry of Health; authorization 896\/2023-PR to E. Zito); Mario Negri Institutional Regulations and Policies providing internal authorization for people conducting animal experiments (Quality Management System Certificate\u2014UNI EN ISO9001: 2008\u2014registration number 6121); EU directives and guidelines (EEC Council Directive 2010\/63\/UE).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"105"}}